Pilocytic astrocytomas are usually cystic; cyst formation within these tumours may result in increased intracranial pressure, due to the effect of their mass, and contribute to cerebral damage. Eosinophilic granular bodies (EGBs) are produced abundantly in pilocytic astrocytomas but their role in disease progression remains unknown. Immunohistochemistry studies showed EGBs to exhibit pronounced reactivity to antibodies against lysosome-associated membrane proteins (LAMP)-1 and LAMP-2, and the lysosomal enzyme cathepsin D. Both LAMP-1 and LAMP-2 showed peripheral rim and granular staining patterns. The EGBs were scattered widely across cysts and, where EGBs aggregated in clusters, were usually close to areas of fluid in the cysts. Most EGBs had nuclei either attached or close by, indicating that the EGBs may be derived from anucleated astrocytes. The results suggest that EGBs, together with other factors, may play a role in the development of cysts in pilocytic astrocytomas.
Introduction
Pilocytic astrocytomas (World Health Organization [WHO] grade I) are generally slow-growing cystic astrocytomas that occur in children and young adults. Cyst formation and growth within the brain may result in increased intracranial pressure, due to a mass effect, and may cause brain damage and dysfunction. 1 The most common signs and symptoms of pilocytic astrocytomas are macrocephaly, headache, nausea and ventricular obstruction. 1 Pilocytic astrocytomas are biphasic astrocytic tumours, characterized by alternating layers of densely compacted bipolar cells with Rosenthal fibres and loosely textured multipolar cells with microcysts and eosinophilic granular bodies (EGBs). 1 Also known as hyaline granular bodies or eosinophilic hyaline droplets, EGBs are round vesicular bodies observed predominantly in pilocytic astrocytomas and in brain tumours such as gangliogliomas and pleomorphic xanthoastrocytomas. 2 EGBs are recognized as brightly eosinophilic round bodies of variable size in periodic acid-Schiff (PAS) and haematoxylin and eosin (H&E)-stained sections. 1 Previous studies investigating EGBs have shown that they are positively reactive for α 1 -antichymotrypsin (AACT), α 1 -antitrypsin (AAT) and lysozyme. 3 A member of the serine proteinase inhibitor (serpin) family, AACT can protect tissue from damage by inhibiting the activity of certain proteinases, 4 and AAT, a serum trypsin inhibitor, can also protect tissues from proteases produced by inflammatory cells. 5 Lysozymes, which kill bacteria by damaging the bacterial cell wall, are abundant in tears, saliva, mucus and the cytoplasmic granules of polymorphonuclear neutrophils. 6 The presence of AACT, AAT and lysozymes in EGBs has been thought to be related to tumour cell protection in response to regional proteolysis or inflammatory activity. 7 It has been proposed that EGBs are related to the lysosomal system. 3 Lysosomes possess various powerful enzymes that can digest macromolecules. 8 The lysosome-associated membrane proteins (LAMP)-1 and -2 contribute to approximately 50% of all proteins in the lysosomal membrane; they are important for lysosomal biogenesis and enzyme targeting, and for maintaining the structural integrity of the lysosomal compartment. 8 The formation of cysts in tissue involves the degradation of adjacent connective tissue. 9 Collagen is the main protein component in animal connective tissue and lysosomal enzymes are implicated in collagen degradation. 10 Studies report that lysosomes are involved in unicameral bone cyst pathogenesis and the formation of cysts in the brain of stroke-prone spontaneously hypertensive rats. 11, 12 Cathepsin D is a major lysosomal proteinase that is very important in maintaining the normophysiological condition as well as participating in various lysosome-mediated pathological processes. 13 The cellular apoptosis susceptibility (CSE1L/CAS or CSE1L) protein is present in high levels in cancer. 14 CSE1L can regulate apoptosis induced by interferon-γ and chemotherapeutic drugs. 15 -17 Our previous research has demonstrated that CSE1L is a secretory protein 18 that regulates matrix metalloproteinase (MMP)-2 translocation and secretion, and cancer cell metastasis. 19 -21 Since CSE1L regulates cell secretion, it was postulated whether it may be involved in the translocation or secretion of biochemical entities to EGBs.
Because EGBs are related to the lysosomal system and are produced abundantly in pilocytic astrocytoma cysts, and lysosomes are involved in cyst development in tissue, EGBs may also be involved in the development of these cysts. The presence of LAMP-1, LAMP-2 and cathepsin D in EGBs in pilocytic astrocytomas has not been studied. Thus the present study was designed to evaluate the distribution of LAMP-1, LAMP-2, cathepsin D and CSE1L in pilocytic astrocytomas, particularly their distribution in EGBs. The possible involvement of LAMP-1, LAMP-2 and cathepsin D in the development of cysts in pilocytic astrocytomas is also discussed. 
Patients and methods

PATIENTS AND TUMOUR MATERIALS
This retrospective observational study used anonymous unlinked and 'as excess' samples approved by the Ethics Committees of the Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan and the Changhua Christian Hospital, Changhua, Taiwan. Records of patients with brain tumours who had been treated at the hospitals between June 2001 and October 2008, were reviewed to identify cases of pilocytic astrocytoma. Then, specimens of these tumours were obtained from each hospital following the approved guidelines (IRB Nos 98014 and 080322) of the Institutional Review Boards.
ANTIBODIES
The following antibodies were used in this study: Anti-LAMP-1 (H228), anti-LAMP-2 (H207), anti-MMP-2 (H-76) (all from Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-CSE1L (clone 3D8) (Abnova, Taipei, Taiwan), anti-MMP-9 (EP1328Y), anti-CD34 (clone QBEnd/10) (both from Novus Biologicals, Littleton, CO, USA), anticathepsin D (clone 49) (BD Biosciences Pharmingen, San Diego, CA, USA) and antiglial fibrillary acidic protein (anti-GFAP) (NCL-GFAP; Novocastra, Newcastle-upon-Tyne, UK).
IMMUNOHISTOCHEMISTRY AND PAS STAINING
Immunohistochemistry was carried out on 4-µm formalin-fixed/paraffin-embedded pilocytic astrocytoma sections. After deparaffinization in xylene and rehydration in graded ethanol, sections were immersed in 10 mM citrate buffer, pH 6.0, at 95°C for 10 min for antigen retrieval. Immunohistochemisty was carried out using a labelled streptavidin-biotin method with 50-fold dilution of the above-mentioned antibodies and a Histostain™ kit (Zymed Laboratories Inc., San Francisco, CA, USA) according to the manufacturer's instructions. Sections were developed with diaminobenzidine, washed with distilled water and counterstained with Mayer's H&E. 22 For PAS staining, sections were directly stained with PAS reagent following antigen retrieval.
MICROSCOPICAL EXAMINATION
Tumour sections were examined and evaluated independently by two pathologists with an Olympus IX51 inverted microscope (Olympus Corp., Tokyo, Japan). The evaluation and classification of tumours were carried out according to WHO criteria for tumours of the nervous system. 1
Results
Records from 70 patients with brain tumours were examined, five of which were found to be pilocytic astrocytomas. Specimens from these five tumours, which had been obtained at diagnosis, were further examined and evaluated independently by two pathologists and were used in the present study. Tumours had been diagnosed according to WHO criteria for the classification of tumours of the nervous system. Baseline characteristics of the five cases of pilocytic astrocytomas are shown in Table 1 .
Microscopical examination of the specimens showed a biphasic combination of areas with focal microcystic and prominent compact solid areas in the tumour sections. The tumour cells generally showed mild nuclear atypia. Oligodendroglioma-like honeycomb cells were observed, and bright eosinophilic and corkscrew-shaped Rosenthal fibres were present in compact solid tumour areas. In the loose-textured microcystic areas of the pilocytic astrocytoma specimens, EGBs were observed; they were positive in PAS and brightly eosinophilic in H&E staining (data not shown). The PAS staining determined that the EGBs were homogeneous, finely granular and surrounded by a ruffled membrane (data not shown). The H&E staining occurred predominantly in granular materials that were distributed in areas close to the membrane of EGBs (data not shown). Anti-GFAP antibodies in EGBs had different staining patterns: some EGBs showed peripheral rim-staining with anti-GFAP antibodies (Fig. 1A) ; others showed homogenous staining in whole bodies (Fig.  1B) . These results indicate that the content of each EGB may be different.
Immunohistochemical studies showed positive CSE1L staining in the cytoplasm and extracellular areas of astrocytes (Fig. 1C ). Positive CSE1L staining was also observed in EGBs and the anti-CSE1L antibody-reactive materials showed a fine granular staining pattern in the whole inclusions of the EGBs of pilocytic astrocytomas (Fig. 1D ). There was little staining for MMP-2 and MMP-9 in EGBs in pilocytic astrocytomas ( Fig. 1E and 1F) .
Immunohistochemistry studies showed both peripheral rim and granular staining patterns of LAMP-1 and LAMP-2 in EGBs from pilocytic astrocytomas ( Fig. 2A and 2B ). LAMP-1 and LAMP-2 were also expressed in the cytoplasm of neoplastic astrocytes in pilocytic astrocytomas, and LAMP-1 and LAMP-2 staining was stronger in EGBs than in the cytoplasm of neoplastic astrocytes in pilocytic astrocytomas ( Fig. 2A and 2B) . Studies using anticathepsin D antibodies showed a fine granular staining pattern of this lysosomal protease in the whole bodies of EGBs in pilocytic astrocytomas (Fig. 2C) . The EGBs were scattered widely across cysts in the pilocytic astrocytoma specimens and, where EGBs aggregated in clusters, were frequently close to fluid areas in the cysts (Fig. 3A, Table 1 ). Some cysts were lined by EGBs of irregular, but generally globular, outline ( Fig. 3B and 3C) .
The data showed that EGBs had distinct nuclei (Fig. 4 ). Some EGBs had condensed nuclei ( Fig. 4A -4D ), while others had nuclei with rope-like cytoplasmic remnants ( Fig. 4E  -4H ). Some EGB membranes were sticky, with fragmented nuclei (Fig. 4F and 4I ). There was no indication of EGBs secreted by intact neoplastic astrocytes.
Discussion
Pilocytic astrocytomas are usually cystic and are generally low-grade, slow-growing tumours. Given the slow growth rate of these astrocytomas, the growth and extension of cystic lesions -rather than increased tumour mass caused by tumour cell proliferationmight account for their clinical presentation. Lysosomes and their proteinases, including their main protease, cathepsin D, can destroy the extracellular matrix of connective tissue and are involved in cyst formation during the progression of various diseases. 10 -13 Since LAMP-1, LAMP-2 and cathepsin D are the main components of lysosomes and EGBs are related to the lysosomal system, we assessed whether LAMP-1, LAMP-2 and cathepsin D would be present in EGBs in pilocytic astrocytomas and found that they were present. Immunohistochemistry showed EGBs scattered widely across the cysts of these tumours and, where EGBs aggregated in clusters, were frequently close to fluid areas in the cysts. Some cysts were lined by EGBs of irregular, but generally globular, outline.
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Although EGBs are produced abundantly in pilocytic astrocytomas, their role in disease progression remains unclear. We attempted to investigate this in the present study, however only five specimens from patients with pilocytic astrocytomas who attended Tungs' The mechanism of EGB formation is not fully known. If EGBs are derived from lysosomes and secreted outside of neoplastic astrocytes in pilocytic astrocytomas, it is possible that they may be anucleated. The present study showed that there was a distinct nucleus attached or close to each EGB, indicating that some EGBs may be derived from anucleated apoptotic astrocytoma cells. It was also shown that EGBs stained heavily for LAMP-1, LAMP-2 and cathepsin D, with that for LAMP-1 and LAMP-2 particularly pronounced. LAMP-1 and LAMP-2 play important roles in lysosomal biogenesis, lysosomal enzyme targeting and maintenance of the structural integrity of the lysosomal compartment. 8 Thus, the distribution of EGBs in pilocytic astrocytomas may result from the high expression of LAMP-1 and LAMP-2 in astrocytoma cells, which induces abnormally pronounced lysosome production in these cells. Cathepsin D is a key mediator of cell apoptosis; 23 high accumulation of cathepsin D and other lysosomal proteases may induce apoptosis of astrocytoma cells that produce substantial levels of lysosomes. On the other hand, however, high expression of LAMP-1 and LAMP-2 in apoptotic astrocytoma cells may contribute to maintaining the structural integrity of the membranes of these cells and production of EGBs.
The protein, CSE1L, regulates cancer cell secretion; 18 -20 in particular, previous research has shown that it regulates MMP-2 translocation and secretion. 19, 20 MMP-2 and MMP-9 play various pathophysiological roles 24 -27 including cancer progression 28, 29 and cyst development in brain tumours. 30 Since CSE1L is present in EGBs, the current study investigated whether MMP-2 and MMP-9 were also present in EGBs and found that, although MMP-2 and MMP-9 were present in the extracellular areas of neoplastic astrocytes in pilocytic astrocytomas, no significant staining was observed in EGBs. It is reasonable that MMP-2 and MMP-9 were not stained in EGBs, since these are not lysosomal proteases and may be degraded completely in EGBs. The EGBs are involved with the lysosome-related system and positive staining for CSE1L in EGBs indicates that CSE1L is secreted in the tumour and may play a role in mediating the translocation of some proteases into lysosomes.
Although pilocytic astrocytomas are generally benign, cases of malignant transformation have been reported. 31 -34 The proliferation indices of cases of malignant transformation of pilocytic astrocytomas, in both primary lesions and implants, are low. 32 Radiation may induce fast-growing malignant brain tumours and may be one factor that accounts for the malignant changes seen in some pilocytic astrocytomas. 33,34 A literature search based study of 52 purported cases of malignant transformation of pilocytic astrocytomas showed that WHO grade I pilocytic astrocytomas do not undergo spontaneous anaplastic transformation and that malignant transformations have only been demonstrated following radiation therapy. 35 Interestingly, radiation has been reported to increase the activity of cathepsin D. 36, 37 Cathepsin D is involved in brain cancer progression. 38 Thus, its presence in the EGBs of pilocytic astrocytomas may be somewhat related to the malignant transformation of these tumours following radiation therapy.
Cyst formation in pilocytic astrocytomas may contribute to increased intracranial pressure due to a mass effect of these tumours, thereby leading to cerebral damage and neurological disorders. The present study suggested that EGBs are lysosome-related granular bodies that may, to some extent, be involved in the development of cysts in pilocytic astrocytomas. These findings may help to provide new insight into the role of EGBs in pilocytic astrocytomas which, in turn, may be useful for the treatment of pilocytic astrocytoma.
